The Whos Who of the biotech industry relies on Austria. Every second biotechnology company is located in the hotspot of Vienna, where a leading research centre the Campus Vienna BioCenter has emerged. Multinationals and startups benefit from an extensive value chain, from basic research to production and distribution. The national investment promotion agency Austrian Business Agency (ABA) is the first point of contact when making the leap into the Austrian market.
Richter-Helm is a leading and expanding Germany-based contract development and manufacturing organization (CDMO). Richter-Helm provides excellent services in the continuously growing market of pharmaceutical biotechnology. Offering a broad range of microbial manufacturing, development and analytical services, Richter-Helm will bring customer projects to the next level.
The success of any adoptive cell therapy lies in how effectively and selectively engineered immune cells interact and kill cancer cells. Functional phenomics enables insights that can dramatically accelerate the development of next-gen cell therapies. evorion biotechnologies brings functional phenomics to pharma and biotech partners via exclusive access to a unique, proprietary pipeline for in-depth multi-modal analysis of thousands of cell-cell interactions at single-cell resolution.
This whitepaper provides insights into why it is critical to manage, optimize and streamline a supply chain to mitigate risks, such as those brought on by the COVID-19 pandemic.
Small-volume biopharmaceutical processes continue to grow as more biopharmaceutical, cell therapy and gene therapy companies develop products. A 2021 Association for Regenerative Medicine (ARM) report states that there are 1,085 cell, gene and tissue-based therapy developers worldwide. These companies are engaged in many small-volume (<10L) processes including early-stage drug development and autologous therapies.
Early phase clinical trials require expert support, often across many service areas and specialisms. Recruitment for trials can be complicated, with less flexibility and higher costs as you attempt to acquire top talent on a project-only basis. Thats why CROs are becoming increasingly indispensable. CROs offer fully formed, multi-skilled teams ready to go, who you can bring on board as and when needed.
mRNA technology has revolutionized vaccine development. What are the chemical components that make up a typical mRNA vaccine and what are their functions? What analytical testing can be done to support this?
This year LKF Central Laboratory, which specialises in international clinical trials, celebrates its 30th anniversary. Although size and services have developed significantly since the beginning, LKF´s corporate philosophy is still the same. With its dedicated team, LKF supports clinical trials with an individual and study-oriented, flexible approach with consistent high-quality laboratory standards.
This white paper explores vaccine development during a pandemic, a response to complex challenges that traditional manufacturing methods won’t solve.
This white paper explores the drug repurposing, where known clinical candidates or commercially approved molecules are evaluated for new targets and indications.